undamentalytics Newsletter
Sign in

Iradimed Corp cash flow statement

In fiscal 2025, Iradimed Corp's operations generated $24.9m of cash; it spent $7.8m on capital projects, leaving free cash flow of $17.2m. It returned $15.0m in dividends.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations138937106111013262527
Depreciation and amortisation00111111111111
Stock-based pay01122224112333
Capital spending01011000017881
Free cash flow1279371051196181726
Free cash flow after stock pay11670581984151423
Dividends paid—————————1313141516
Share buybacks———102—————————
Shares issued—14————————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: IRMD vs LUNGDCTH vs IRMDIRMD vs SGHT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Iradimed Corp's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Iradimed Corp.